The largest database of trusted experimental protocols

Sas v9

Manufactured by GraphPad
Sourced in United States

SAS v9.4 is a statistical software package developed by SAS Institute. It provides a comprehensive suite of tools for data analysis, statistical modeling, and reporting. The software is designed to handle a wide range of data types and offers a variety of procedures and functions for statistical inference, regression analysis, and multivariate techniques.

Automatically generated - may contain errors

20 protocols using sas v9

1

Statistical Analysis Techniques for Biological Research

Check if the same lab product or an alternative is used in the 5 most similar protocols
Statistical analysis was performed using a two-tailed Student’s t-test or a Mann-Whitney U test for comparisons between two groups, a one-way ANOVA with Tukey’s multiple comparisons for comparisons more than 2 groups, or the Mantel-Cox method (log-rank test) for survival analysis using GraphPad Prism 8.02 (GraphPad Software). Correlations were assessed using the Pearson and Spearman correlation coefficients. Analyses were performed in GraphPad Prism 8.02 (GraphPad Software) and SAS v9.4 (Cary, NC) at a significance level of 0.05.
+ Open protocol
+ Expand
2

Immune Response Analysis in Clinical Trial

Check if the same lab product or an alternative is used in the 5 most similar protocols
Follow-up was complete by December 2016, by which point all patients had progressed or were receiving other treatments. Datasets were tested for normality, and appropriate tests were used to compare patient immune responses at specified time points during the trial (nonparametric: Wilcoxon signed rank test, parametric: paired t test). Error bars represent mean ± SEM where appropriate. PFS was analyzed using log-rank tests and displayed using Kaplan–Meier plots. P < 0.05 was considered statistically significant and all tests of significance were two-sided. Analyses were performed using SAS v9.4 and GraphPad Prism v7.
+ Open protocol
+ Expand
3

Effects of PRAX-944 on NREM Sleep

Check if the same lab product or an alternative is used in the 5 most similar protocols
Statistical analyses were conducted using SAS v9.4 and GraphPad Prism 7.0. For Part B, absolute NREM σ‐power values for each electrode on each day of testing were natural‐log (ln) transformed to conform with normality assumptions and averaged across the central nine electrodes. A mixed model repeated measures (MMRM) method was used for analysis of group differences in NREM σ‐power change from baseline, which included timepoint, treatment (PRAX‐944 or placebo), and treatment‐by‐timepoint interaction as fixed factors, and baseline value as a covariate. Model‐based point estimates (ie, least square [LS] mean change for each treatment group and the difference between treatment groups), 95% confidence interval (95% CI) for the difference, and P values are reported for each assessment timepoint.
+ Open protocol
+ Expand
4

Non-Parametric Statistical Analyses

Check if the same lab product or an alternative is used in the 5 most similar protocols
All experiments were performed in at least triplicate and specific sample sizes are denoted in the Results. Non-parametric Kruskal–Wallis testing was performed to determine statistical significance using SAS v9.4, and GraphPad Prism v6. Significance was set as P<0.05 for all experiments. Experimental groups were compared to a control group that combined all sham animals from all trials to increase power and reduce animal numbers. Separate analysis of sham-treated animals was performed using non-parametric Kruskal–Wallis tests to determine that no statistical differences existed between these groups in any individual trials.
+ Open protocol
+ Expand
5

Revumenib Dose-Escalation Safety Study

Check if the same lab product or an alternative is used in the 5 most similar protocols
All patients who received at least one dose of revumenib were included in the safety analysis, whereas only those with KMT2Ar or mutated NPM1 were included in the efficacy analysis. Time-to-event end points were estimated using the Kaplan–Meier method. Descriptive statistics were used for other clinical, laboratory and pharmacokinetic variables. Clinical data were captured in Medidata Classic Rave 2021.2.0, and data analyses were performed using SAS v.9.4 and GraphPad Prism v.8.0. Changes in gene expression were analysed using a paired t-test.
RP2D was determined by the safety review committee based on review of pharmacokinetics, safety and tolerability data among evaluable patients.
+ Open protocol
+ Expand
6

Statistical Analysis of Experimental Data

Check if the same lab product or an alternative is used in the 5 most similar protocols
All experiments were performed in at least triplicate and specific sample sizes are denoted in the results and/or figure legends. Non-parametric Kruskal–Wallis testing and Student t-tests were performed as appropriate to determine statistical significance using SAS v9.4 and Graph Pad Prism v8. Significance was set as P<0.05 for all experiments. In gene expression analyses, only results that were mathematically significant and greater than twofold different were considered clinically significant. All error bars are s.e.m. measurements.
+ Open protocol
+ Expand
7

Neuronal Size Changes After Axotomy

Check if the same lab product or an alternative is used in the 5 most similar protocols
IBM SPSS V24, SAS V9.4 and GraphPad Prism were used. The distribution of the data was evaluated with Kolmogorov-Smirnov test. Paired t-test for ratios or Wilcoxon test was used to compare neuronal size before and after axotomy. Though some datasets had a normal distribution, most of them did not, therefore, non-parametric tests were used for group comparisons. The distribution of a continuous marker was compared among two or more levels of a factor of interest by using Mann-Whitney test. Correlation analysis was used to analyze relationship between two variables. Change of marker overtime was modeled through random-coefficient models using the MIXED procedure in SAS, where spatial-power of time-lag covariance structure was used to account for the correlation structure among measurements. Similarly, repeated-measures models with variance-components covariance structure were also constructed using the MIXED procedure. To estimate the impact of a given predictor on the likelihood of survival, univariable Logistic regression was used and the significance of the predictor was assessed through both p values and Area Under the curve (AUC). A p < 0.05 is considered significant. Details of statistical methods used for individual experiments can be found in figure legends.
+ Open protocol
+ Expand
8

Statistical Analysis of In Vitro Experiments

Check if the same lab product or an alternative is used in the 5 most similar protocols
The statistical analyses were performed using Statistical Analysis System (SAS) v9.4 and Prism v6.0 (GraphPad Software Inc., San Diego, CA, USA). The results of in vitro experiments were analyzed by using ANOVA with Duncan’s multiple comparison tests. The other results were analyzed by using ANOVA with Tukey’s multiple comparison test or Dunnett’s multiple comparison tests. The values were described as mean ± SD, and the p value of <0.05 was considered significant.
+ Open protocol
+ Expand
9

Statistical Analysis of Experimental Data

Check if the same lab product or an alternative is used in the 5 most similar protocols
Differences between two groups were evaluated using unpaired two tailed Student’s t-test. Multiple group comparisons were performed using one-way ANOVA, and then the different types of post-hoc multiple comparisons tests. Differences at *p < 0.05 were considered significant. Statistical analyses were performed using SAS v9.4 or GraphPad Prism software.
+ Open protocol
+ Expand
10

Comparison of Continuous Data Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Continuous data were tested across two groups with independent or paired Student’s t test; for three or more groupings, ANOVA or mixed model regression (for matched data) followed by Tukey’s test was used to correct for multiple group comparisons. Residuals were inspected to confirm fit of data, and where outliers were present, data were log-transformed prior to analysis. Data are presented as mean ± SEM. Differences were considered significant where two-tailed p values were < 0.05. SAS v9.4 and GraphPad v7 software were used for analysis. Data are graphed as percent of control (100%), but statistical testing was performed on raw numbers.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!